The deal will be an asset sale of the sites in Germany, Indonesia and Brazil and will provide for tolling agreements where necessary.

Quats – or quaternary ammonium compounds – are a group of chemicals used for various purposes, including as preservatives, surfactants and antistatic agents. The sale includes products sold under the Praepagen and Genamin trademarks that Clariant said have a well-established presence in the home and personal care market.

“The quats and esterquats business is an ideal fit for Global Amines Company as it perfectly complements our product portfolio and our ability to offer customers the best and most competitive solutions from a complete range of amines, quats, amines derivatives and betaines,” said Ernesto Horikoshi, group general manager of Global Amines.

He added: “The acquisition plays to the JV’s strategic strengths by building on Clariant’s long-standing experience in specialties chemicals and Wilmar’s position as Asia’ leading agribusiness and on its global oleochemicals business. This will guarantee a solid business continuity on a competitive and attractive basis for an ever-stronger future growth.”

The transaction, which remains subject to regulatory approvals and the usual closing conditions, is expected to complete in the first half of 2023.

Clariant said the divestment is a further step in its transformation to focus its operations purely on specialty chemicals.

Author: Elaine Burridge, Freelance Author